Conference Chair
Sunitha Nagrath
Professor of Chemical Engineering and Biomedical Engineering, University of Michigan-Ann Arbor |
 Keynote Speakers
Sunitha Nagrath
Professor of Chemical Engineering and Biomedical Engineering, University of Michigan-Ann Arbor | 
Daniel Hayes
Stuart B. Padnos Professor of Breast Cancer Research, University of Michigan Rogel Cancer Center | 
Ian Papautsky
Richard and Loan Hill Professor of Bioengineering, Co-Director, NSF Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of Illinois at Chicago |
OverviewSelectBIO Liquid Biopsies 2024 focuses primarily on
biofluid-based molecular biomarkers, such as circulating tumor DNA
(ctDNA), Extracellular Vesicles (Exosomes) as well as circulating tumor cells (CTCs), and protein-based
circulating biomarkers. There is much interest in the potential of
ctDNA for developing biological fluid-based biopsies (such as using
plasma, urine, or other biofluids) and the presenters in this track
bring together the most up-to-date information and current
state-of-the-field.
The conference further explores the potential
of various minimally-invasive circulating
biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and
Extracellular Vesicles (EVs), for development of novel diagnostics for
early disease screening, patient monitoring and minimal residual disease
detection.
This conference is held concurrently with the Innovations in Microfluidics 2024 Conference
enabling delegates full access to the scientific presentations in both
conferences, co-located exhibit hall, and extensive networking
opportunities.
Professor Sunitha Nagrath, Professor at the University of Michigan-Ann Arbor is serving as Conference Chairperson of Liquid Biopsies 2024 Conference
Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 01 May 2024
|
Agenda Topics- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA) and Exosomes/EVs: Potential for Development of Liquid Biopsies
- Emerging Technologies and Emerging Companies Showcase
- Technology Platforms
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
- Microfluidics Platforms for Diagnostics Development
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2024-05-06 00:00:002024-05-07 00:00:00Europe/LondonLiquid Biopsy 2024: Technologies and ApplicationsLiquid Biopsy 2024: Technologies and Applications in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com
